A review on metabolic syndrome
Keywords:
metabolic syndrome, obesity, inflammation, diabetes, dietAbstract
Metabolic syndrome is considered a major reason for the emergence of chronic dreadful diseases. Obesity and wrong food habit are key factors for metabolic syndrome. Globally people are affected by glucose intolerance, central obesity, hypertension, and dyslipidemia. Diabetes is a major part of metabolic syndrome. Targeted anti-inflammatory therapy has been suggested for both prevention and treatment of many of the above-said syndrome especially diabetes. Diet is an important regulatory factor in the immune response. There is considerable evidence to suggest that malnutrition leads to immune suppression due to a susceptibility to infection. On the other hand, over-nutrition leads to immune activation due to a susceptibility to an inflammatory condition. Inflammation may have an important role in the development and progression of diabetes and its complications; however, the impact of experimental anti-inflammatory treatments on diabetes deterioration over time and cardiovascular outcomes is still elusive. Thus proper diet with some drug therapy not only resolves the issue but can prevent the progression of the disease at extreme levels.
Downloads
References
Sharma P. Inflammation and the metabolic syndrome. Indian J Clin Biochem. 2011;26(4):317–8.
Mittra S, Bansal VS, Bhatnagar PK. From a glucocentric to a lipocentric approach towards metabolic syndrome [Internet]. Vol. 13, Drug Discovery Today. Drug Discov Today; 2008 [cited 2021 Jun 19]. p. 211–8. Available from: https://pubmed.ncbi.nlm.nih.gov/18342796/
De Ferranti S, Mozaffarian D. The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences [Internet]. Vol. 54, Clinical Chemistry. Clin Chem; 2008 [cited 2021 Jun 19]. p. 945–55. Available from: https://pubmed.ncbi.nlm.nih.gov/18436717/
Hotamisligil GS. Inflammation and metabolic disorders [Internet]. Vol. 444, Nature. Nature; 2006 [cited 2021 Jun 19]. p. 860–7. Available from: https://pubmed.ncbi.nlm.nih.gov/17167474/
Sikaris KA. The clinical biochemistry of obesity. Clin Biochem Rev [Internet]. 2004;25(3):165–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18458706%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC1880830
Björntorp P. Metabolic implications of body fat distribution. Diabetes Care [Internet]. 1991 [cited 2021 Jun 19];14(12):1132–43. Available from: https://pubmed.ncbi.nlm.nih.gov/1773700/
Burton BT, Foster WR, Hirsch J, Van Itallie TB. Health indications of obesity: An NIH consensus development conference. Int J Obes. 1985;9(3):155–70.
N T, Ngah N, Estella FT, GA A. Herbal Medicine and Treatment of Diabetes in Africa: Case Study in Cameroon. Diabetes Case Reports. 2017;01(02):1–6.
Al-Adsani H, Hoffer LJ, Silva JE. Resting Energy Expenditure is Sensitive to Small Dose Changes in Patients on Chronic Thyroid Hormone Replacement 1 . J Clin Endocrinol Metab [Internet]. 1997 Apr [cited 2021 Jun 19];82(4):1118–25. Available from: https://pubmed.ncbi.nlm.nih.gov/9100583/
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation - PubMed [Internet]. [cited 2021 Jun 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/9686693/
Cleeman JI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc [Internet]. 2001 May 16 [cited 2021 Jun 19];285(19):2486–97. Available from: https://pubmed.ncbi.nlm.nih.gov/11368702/
Hanley AJG, Wagenknecht LE, D’agostino RB, Zinman B, Haffner SM. Identification of Subjects with Insulin Resistance and-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome. 2003.
Laaksonen DE, Lakka H-M, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic Syndrome and Development of Diabetes Mellitus: Application and Validation of Recently Suggested Definitions of the Metabolic Syndrome in a Prospective Cohort Study. Am J Epidemiol [Internet]. 2002;156(11):1070–7. Available from: https://academic.oup.com/aje/article/156/11/1070/80584
Lee H, Lee IS, Choue R. Obesity, inflammation and diet [Internet]. Vol. 16, Pediatric Gastroenterology, Hepatology and Nutrition. Korean Society of Pediartic Gastroenterology, Hepatology and Nutrition; 2013 [cited 2021 Jun 19]. p. 143–52. Available from: https://pubmed.ncbi.nlm.nih.gov/24224147/
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol [Internet]. 2011 Apr 23 [cited 2021 Jun 19];29:415–45. Available from: https://pubmed.ncbi.nlm.nih.gov/21219177/
Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response [Internet]. Vol. 8, Nature Reviews Molecular Cell Biology. Nature Publishing Group; 2007 [cited 2021 Jun 19]. p. 519–29. Available from: https://www.nature.com/articles/nrm2199
Urano F, Wang XZ, Bertolotti A, Zhang Y, Chung P, Harding HP, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science (80- ). 2000 Jan 28;287(5453):664–6.
Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue: Initiation, propagation and remodeling [Internet]. Vol. 3, Future Lipidology. Future Lipidol; 2008 [cited 2021 Jun 19]. p. 545–56. Available from: https://pubmed.ncbi.nlm.nih.gov/18978945/
Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes [Internet]. 2007 Apr [cited 2021 Jun 19];56(4):901–11. Available from: https://pubmed.ncbi.nlm.nih.gov/17395738/
Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol - Endocrinol Metab [Internet]. 2007 Oct [cited 2021 Jun 19];293(4). Available from: https://pubmed.ncbi.nlm.nih.gov/17666485/
Shi H, Kokoeva M V., Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest [Internet]. 2006 Nov 1 [cited 2021 Jun 19];116(11):3015–25. Available from: https://pubmed.ncbi.nlm.nih.gov/17053832/
Jenkins DJA, Wolever TMS, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am J Clin Nutr [Internet]. 1981 [cited 2021 Jun 19];34(3):362–6. Available from: https://pubmed.ncbi.nlm.nih.gov/6259925/
Joffe YT, Collins M, Goedecke JH. The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids [Internet]. Vol. 5, Nutrients. MDPI AG; 2013 [cited 2021 Jun 19]. p. 1672–705. Available from: www.mdpi.com/journal/nutrients
Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, et al. Nutritional Epidemiology Consumption of (n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in Women 1 [Internet]. Vol. 134, J. Nutr. 2004. Available from: https://academic.oup.com/jn/article/134/7/1806/4688579
Bhupathiraju SN, Tucker KL. Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults. Am J Clin Nutr [Internet]. 2011 Jan 1 [cited 2021 Jun 19];93(1):37–46. Available from: https://pubmed.ncbi.nlm.nih.gov/21068354/
Gregor MF, Okhan G¨, Hotamisligil S. IY29CH16-Hotamisligil ARI Inflammatory Mechanisms in Obesity. 2011; Available from: www.annualreviews.org
Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr [Internet]. 2004 Sep [cited 2021 Jun 19];92(3):347–55. Available from: https://pubmed.ncbi.nlm.nih.gov/15469638/
Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science (80- ) [Internet]. 2001 Aug 31 [cited 2021 Jun 24];293(5535):1673–7. Available from: https://pubmed.ncbi.nlm.nih.gov/11533494/
Pollack RM, Donath MY, LeRoith D, Leibowitz G. Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care. 2016;39(August):S244–52.
Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes [Internet]. 1996 [cited 2021 Jun 24];45(3 SUPPL.):881–5. Available from: https://pubmed.ncbi.nlm.nih.gov/8666137/
Wasko MCM, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, et al. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. J Am Med Assoc [Internet]. 2007 Jul 11 [cited 2021 Jun 25];298(2):187–93. Available from: https://pubmed.ncbi.nlm.nih.gov/17622600/
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
